Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. I. Physician, parent, and patient global assessments-Reference-Cited by-同舟云学术

Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. I. Physician, parent, and patient global assessments

Published:1997-11 Issue:11 Volume:40 Page:1976-1983
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Rider Lisa G.,Miller Frederick W.,Feldman Brian M.,Perez Maria D.,Rennebohm Robert M.,Lindsley Carol B.,Zemel Lawrence S.,Wallace Carol A.,Ballinger Susan H.,Bowyer Suzanne L.,Reed Ann M.,Passo Murray H.,Katona Ildy M.,Lachenbruch Peter A.,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference42 articles.

1. : Polymyositis and dermatomyositis in children. In, Oxford Textbook of Rheumatology. Edited by , , . Oxford, Oxford University Press, 1993

2. Juvenile Dermatomyositis: Pathophysiology and Disease Expression

3. New perspectives on the idiopathic inflammatory myopathies of childhood

4. Disease assessment indices: activity, damage and severity

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis;Arthritis & Rheumatology;2024-07-31

2. Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies – A longitudinal study;Seminars in Arthritis and Rheumatism;2024-04

3. Spontaneous pneumomediastinum in anti-MDA5-positive dermatomyositis: Prevalence, risk factors, and prognosis;Seminars in Arthritis and Rheumatism;2024-04

4. Type 1 Interferon‐Stimulated Gene Expression and Disease Activity in Pediatric Rheumatic Diseases: No Composite Scores Needed?;ACR Open Rheumatology;2023-10-02

5. First-line immunosuppression in neuromuscular diseases;Practical Neurology;2023-05-12